SCHEMBL10399648

SCHEMBL10399648

CN(C)/C=C1\C(=O)N(c2ccc(N(C)C)cc2)c2ccccc21

nearest known ligand 0.68

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 13/20 0.68
APP P05067 9/20 0.68
SNCA P37840 9/20 0.68
ALDH1A1 P00352 5/20 0.55
HSD17B10 Q99714 1/20 0.55
MEN1 O00255 3/20 0.46
KMT2A Q03164 3/20 0.46
HTT P42858 2/20 0.46
USP2 O75604 1/20 0.46
POLB P06746 1/20 0.46
RECQL P46063 1/20 0.46
SMN1; SMN2 Q16637 1/20 0.45
HIF1A Q16665 1/20 0.45
NPSR1 Q6W5P4 2/20 0.43
GAA P10253 2/20 0.43
CES2 O00748 1/20 0.43
BCHE P06276 1/20 0.43
CES1 P23141 1/20 0.43
HCRTR1 O43613 1/20 0.43
PSMD14 O00487 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10399649 1.00 MAPT (0.68) MAPTAPPSNCAALDH1A1HSD17B10
SCHEMBL10399731 0.88 MAPT (0.63) MAPTAPPSNCAALDH1A1HSD17B10
SCHEMBL10399734 0.88 MAPT (0.63) MAPTAPPSNCAALDH1A1HSD17B10
SCHEMBL10398712 0.87 ALDH1A1 (0.56) MAPTAPPSNCAALDH1A1HSD17B10
SCHEMBL10398711 0.87 ALDH1A1 (0.56) MAPTAPPSNCAALDH1A1HSD17B10
SCHEMBL10806982 0.86 ALDH1A1 (0.55) MAPTAPPSNCAALDH1A1HSD17B10
SCHEMBL10806977 0.86 ALDH1A1 (0.55) MAPTAPPSNCAALDH1A1HSD17B10
SCHEMBL10399797 0.84 ALDH1A1 (0.52) MAPTAPPSNCAALDH1A1HSD17B10
SCHEMBL10398743 0.84 ALDH1A1 (0.52) MAPTAPPSNCAALDH1A1HSD17B10
SCHEMBL10399799 0.84 ALDH1A1 (0.52) MAPTAPPSNCAALDH1A1HSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-4977178-A Method of treating anxiety and depression with 1-phenyl-2(1H,3H)-indolone psycho-therapeutic agents PFIZER INC. (US) 1990-12-11 US disclosed
US-4879391-A 1-Phenyl-2(1H,3H)-indolone psychotherapeutic agents PFIZER INC. (US) 1989-11-07 US disclosed
US-4861880-A 1-phenyl-2(1H,3H)-indolone psycho-therapeutic agents PFIZER INC. (US) 1989-08-29 US disclosed
EP-0104860-B1 1-PHENYL-2(1H,3H)-INDOLONE PSYCHO-THERAPEUTIC AGENTS PFIZER INC. (US) 1987-03-18 EP disclosed
US-4476307-A Heteroylidene indolone compounds PFIZER INC. (US) 1984-10-09 US disclosed